Esperion Therapeutics
ESPR
#6133
Rank
โ‚ฌ0.77 B
Marketcap
3,27ย โ‚ฌ
Share price
1.06%
Change (1 day)
13.30%
Change (1 year)

Esperion Therapeutics (ESPR) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ78.93 Million

According to Esperion Therapeutics's latest financial reports the company has โ‚ฌ78.93 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Esperion Therapeutics - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ0.13 B86.97%
2023-12-31โ‚ฌ74.4 M-52.17%
2022-12-31โ‚ฌ0.15 B-32.07%
2021-12-31โ‚ฌ0.22 B-7.64%
2020-12-31โ‚ฌ0.24 B38.33%
2019-12-31โ‚ฌ0.17 B50.74%
2018-12-31โ‚ฌ0.11 B-28.74%
2017-12-31โ‚ฌ0.16 B-17.05%
2016-12-31โ‚ฌ0.20 B3.62%
2015-12-31โ‚ฌ0.19 B123.07%
2014-12-31โ‚ฌ87.02 M100.1%
2013-12-31โ‚ฌ43.49 M783.5%
2012-12-31โ‚ฌ4.92 M306.9%
2011-12-31โ‚ฌ1.2 M
2002-12-31โ‚ฌ42.9 M-46.09%
2001-12-31โ‚ฌ79.58 M6.76%
2000-12-31โ‚ฌ74.54 M1170.58%
1999-12-31โ‚ฌ5.86 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Ultragenyx Pharmaceutical
RARE
โ‚ฌ0.36 B 359.99%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ1.26 B 1,498.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ12.79 B 16,108.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ7.20 B 9,033.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚ฌ0.22 B 185.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚ฌ98.99 M 25.42%๐Ÿ‡บ๐Ÿ‡ธ USA